RxDoctor Payments Data

Theodore Chrobak, DO

Family Medicine · East Liverpool, OHNPI 1245218478

Payments from drug & device makers

$1,432in general payments, 2019–2025

Across 83 payments — averaging $17.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$218
  • AstraZeneca$141
  • AbbVie$135
  • Lilly USA, LLC$119
  • GSK$86
  • Boehringer Ingelheim$81
  • plus $653 from 20 others

What the payments were for

  • Food & beverage$1,432100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,432 in reported general payments places this provider in the 65th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$84,097
Medicare patients
124
Services billed
839

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban63$58,700
Spiriva RespimatTiotropium Bromide61$42,613
XareltoRivaroxaban21$29,850
TrulicityDulaglutide21$29,813
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$24,372
SymbicortBudesonide/Formoterol Fumarate73$18,518
JardianceEmpagliflozin24$18,496
OzempicSemaglutide22$18,263
MyrbetriqMirabegron15$9,496
Humulin 70/30 KwikpenInsulin Nph Hum/Reg Insulin Hm22$9,280
Albuterol Sulfate HfaAlbuterol Sulfate260$8,141
Incruse ElliptaUmeclidinium Bromide13$6,583
LinzessLinaclotide12$6,408
Breo ElliptaFluticasone/Vilanterol13$5,304
Novolin 70-30 FlexpenInsulin Nph Hum/Reg Insulin Hm15$3,509

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimSpiriva Respimat, Jardiance$81$61,10985 claims
PfizerEliquis$218$58,70063 claims
GSKTrelegy Ellipta, Incruse Ellipta, Breo Ellipta$86$36,25852 claims
Johnson & JohnsonXarelto$11$29,85021 claims
Lilly USA, LLCTrulicity$119$29,81321 claims
AstraZenecaSymbicort$141$18,51873 claims
AbbVieLinzess$135$6,40812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in East Liverpool

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →